Voyager Therapeutics Inc (NASDAQ: VYGR) is -41.45% lower on its value in year-to-date trading and has touched a low of $2.64 and a high of $9.55 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VYGR stock was last observed hovering at around $3.28 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $3.32, the stock is 5.11% and 1.33% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.0 million and changing 1.22% at the moment leaves the stock -35.84% off its SMA200. VYGR registered -60.48% loss for a year compared to 6-month loss of -51.60%. The firm has a 50-day simple moving average (SMA 50) of $3.2766 and a 200-day simple moving average (SMA200) of $5.17475.
The stock witnessed a -4.87% gain in the last 1 month and extending the period to 3 months gives it a -20.00%, and is 21.61% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.62% over the week and 5.70% over the month.
Voyager Therapeutics Inc (VYGR) has around 172 employees, a market worth around $183.71M and $66.96M in sales. Profit margin for the company is -126.49%. Distance from 52-week low is 25.52% and -65.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-27.56%).
The EPS is expected to shrink by -75.31% this year
159.0 institutions hold shares in Voyager Therapeutics Inc (VYGR), with institutional investors hold 76.15% of the company’s shares. The shares outstanding are 55.21M, and float is at 45.00M with Short Float at 6.25%. Institutions hold 63.51% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 5.31 million shares valued at $$42.02 million. The investor’s holdings represent 9.2038 of the VYGR Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 5.2 million shares valued at $$41.13 million to account for 9.0087 of the shares outstanding. The other top investors are ECOR1 CAPITAL, LLC which holds 3.92 million shares representing 6.7869 and valued at over $$30.99 million, while VANGUARD GROUP INC holds 5.2641 of the shares totaling 3.04 million with a market value of $$24.04 million.
Voyager Therapeutics Inc (VYGR) Insider Activity
The most recent transaction is an insider sale by Ferguson Toby, the company’s Chief Medical Officer. SEC filings show that Ferguson Toby sold 10,086 shares of the company’s common stock on Apr 02 ’25 at a price of $3.43 per share for a total of $34595.0. Following the sale, the insider now owns 0.16 million shares.
Voyager Therapeutics Inc disclosed in a document filed with the SEC on Apr 02 ’25 that Sandrock Alfred (President and CEO) sold a total of 10,885 shares of the company’s common stock. The trade occurred on Apr 02 ’25 and was made at $3.43 per share for $37336.0. Following the transaction, the insider now directly holds 0.43 million shares of the VYGR stock.
Still, SEC filings show that on Apr 02 ’25, Sandrock Alfred (Officer) Proposed Sale 10,885 shares at an average price of $3.43 for $37369.0. The insider now directly holds shares of Voyager Therapeutics Inc (VYGR).
